DNA Damage/DNA Repair
Research Areas
- MTH1(4)
- PARP(103)
- ATM/ATR(31)
- DNA Alkylating(23)
- DNA Ligases(3)
- DNA Methyltransferase(27)
- DNA-PK(28)
- HDAC(143)
- Nucleoside Antimetabolite/Analogue(195)
- Telomerase(15)
- Topoisomerase(193)
- tankyrase(5)
- Antifolate(33)
- CDK(299)
- Checkpoint Kinase (Chk)(36)
- CRISPR/Cas9(9)
- Deubiquitinase(84)
- DNA Alkylator/Crosslinker(87)
- DNA/RNA Synthesis(580)
- Eukaryotic Initiation Factor (eIF)(33)
- IRE1(25)
- LIM Kinase (LIMK)(12)
- TOPK(6)
- Casein Kinase(59)
- DNA Intercalating Agents(8)
- DNA/RNA Oxidative Damage(13)
- Poly(ADP-ribose) Glycohydrolase (PARG)(5)
- Early 2 Factor (E2F)(2)
- Zinc Finger Protein(1)
Products Related to DNA Damage/DNA Repair(1975)
- GC730735-Aza-4'-thio-2'-deoxycytidineCAS: 169514-76-5Purity: >99.00%
5-Aza-4'-thio-2'-deoxycytidine (5-Aza-T-dCyd) is an orally active DNA metltransferase I (DNMT1) inhibitor.
- GC73079Datopotamab deruxtecanCAS: 2238831-60-0Purity: >98.00%
Datopotamab deruxtecan is a TROP2-targeting antibody-drug conjugate (K D =0.74nM).
- GC73086CDK4/6-IN-15 hydrochloridePurity: >99.00%
CDK4/6-IN-15 drochloride is an orally active and selective CDK4/6 inhibitor.
- GC73112JPS014 TFAPurity: >98.00%
JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC).
- GC73113JPS016 TFAPurity: >98.00%
JPS016 is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC).
- GC73122Val-Ala-PABC-ExatecanCAS: 2845164-91-0Purity: >98.00%
Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC,consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor,).
- GC73123Val-Ala-PABC-Exatecan trifluoroacetateCAS: 2928571-45-1Purity: >98.00%
Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor, ).
- GC73130BasroparibCAS: 1858179-75-5Purity: >98.00%
Basroparib is a potent poly (ADP-ribose) polymerase (PARP) inhibitor, with antineoplastic activity.
- GC73132Mal-PEG8-Val-Ala-PAB-ExatecanCAS: 2679821-39-5Purity: >99.00%
Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC linker) that binds to Nectin-4 polypeptides conjugated to chemotherapeutic agents.
- GC73158L2H2-6OTD diformicPurity: >99.00%
L2H2-6OTD acetate contains one to four G-quadruplex binding loops and is a telomere inhibitor analog.
- GC73170eIF4A3-IN-9CAS: 1402931-71-8Purity: >99.00%
eIF4A3-IN-9 (compound 57) is a silvestrol analogue.
- GC73171eIF4A3-IN-12CAS: 1402931-76-3Purity: >99.00%
eIF4A3-IN-12 (compound 62) is a silvestrol analogue.
- GC73172eIF4A3-IN-16CAS: 1402931-74-1Purity: >98.00%
eIF4A3-IN-16 (compound 60) is a silvestrol analogue.
- GC73177USP7-IN-10 hydrochloridePurity: >99.00%
USP7-IN-10 drochloride (compound 1) is a potent ubiquitin-specific protease 7 (USP7) inhibitor, with an IC50 of 13.39 nM.
- GC731795'-ODMT cEt N-Bz A Phosphoramidite (Amidite)CAS: 1197033-19-4Purity: >98.00%
5'-ODMT cEt N-Bz A Phosphoramidite Amidite is a locked nucleic acid (LNA) analogue.
- GC73183CDK8-IN-12CAS: 2613307-67-6Purity: >99.00%
CDK8-IN-12 is an orally active, potent CDK8 inhibitor with a Ki of 14 nM.
- GC73189MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-ExatecanCAS: 2414254-51-4Purity: >97.00%
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan.
- GC73190MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-ExatecanCAS: 2414254-52-5Purity: >95.00%
MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73073 | 5-Aza-4'-thio-2'-deoxycytidine | 169514-76-5 | >99.00% | |
5-Aza-4'-thio-2'-deoxycytidine (5-Aza-T-dCyd) is an orally active DNA metltransferase I (DNMT1) inhibitor. | ||||
| GC73079 | Datopotamab deruxtecan | 2238831-60-0 | >98.00% | |
Datopotamab deruxtecan is a TROP2-targeting antibody-drug conjugate (K D =0.74nM). | ||||
| GC73086 | CDK4/6-IN-15 hydrochloride | - | >99.00% | |
CDK4/6-IN-15 drochloride is an orally active and selective CDK4/6 inhibitor. | ||||
| GC73100 | Senexin C | 2375554-02-0 | >98.00% | |
Senexin C is a selective and orally active CDK8/19 inhibitor. | ||||
| GC73112 | JPS014 TFA | - | >98.00% | |
JPS014 TFA is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC). | ||||
| GC73113 | JPS016 TFA | - | >98.00% | |
JPS016 is a benzamide-based Von Hippel-Lindau (VHL) E3-ligase proteolysis targeting chimeras (PROTAC). | ||||
| GC73118 | EB1 | 42951-68-8 | >99.00% | |
EB1 is the inhibitor of kinases MNK with IC50s of 0.69 μM (MNK1) and 9.4 μM (MNK2). | ||||
| GC73122 | Val-Ala-PABC-Exatecan | 2845164-91-0 | >98.00% | |
Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC,consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor,). | ||||
| GC73123 | Val-Ala-PABC-Exatecan trifluoroacetate | 2928571-45-1 | >98.00% | |
Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor, ). | ||||
| GC73130 | Basroparib | 1858179-75-5 | >98.00% | |
Basroparib is a potent poly (ADP-ribose) polymerase (PARP) inhibitor, with antineoplastic activity. | ||||
| GC73132 | Mal-PEG8-Val-Ala-PAB-Exatecan | 2679821-39-5 | >99.00% | |
Mal-PEG8-Val-Ala-PAB-Exatecan (Compound 9b) is an antibody-drug conjugate linker (ADC linker) that binds to Nectin-4 polypeptides conjugated to chemotherapeutic agents. | ||||
| GC73136 | VPC-70063 | 13571-44-3 | >99.00% | |
VPC-70063 is a potent Myc-Max inhibitor with an IC50 value of 8.9 μM for Myc-Max transcriptional activity inhibition. | ||||
| GC73156 | USP1-IN-3 | 2821749-58-8 | >99.00% | |
USP1-IN-3 is a selective USPI inhibitor. | ||||
| GC73158 | L2H2-6OTD diformic | - | >99.00% | |
L2H2-6OTD acetate contains one to four G-quadruplex binding loops and is a telomere inhibitor analog. | ||||
| GC73166 | U7D-1 | - | >99.00% | |
U7D-1 is a first-in-class potent and selective USP7 (ubiquitin-specific protease 7) PROTAC degrader, with a DC50 of 33 nM in RS4;11 cells. | ||||
| GC73170 | eIF4A3-IN-9 | 1402931-71-8 | >99.00% | |
eIF4A3-IN-9 (compound 57) is a silvestrol analogue. | ||||
| GC73171 | eIF4A3-IN-12 | 1402931-76-3 | >99.00% | |
eIF4A3-IN-12 (compound 62) is a silvestrol analogue. | ||||
| GC73172 | eIF4A3-IN-16 | 1402931-74-1 | >98.00% | |
eIF4A3-IN-16 (compound 60) is a silvestrol analogue. | ||||
| GC73177 | USP7-IN-10 hydrochloride | - | >99.00% | |
USP7-IN-10 drochloride (compound 1) is a potent ubiquitin-specific protease 7 (USP7) inhibitor, with an IC50 of 13.39 nM. | ||||
| GC73179 | 5'-ODMT cEt N-Bz A Phosphoramidite (Amidite) | 1197033-19-4 | >98.00% | |
5'-ODMT cEt N-Bz A Phosphoramidite Amidite is a locked nucleic acid (LNA) analogue. | ||||
| GC73183 | CDK8-IN-12 | 2613307-67-6 | >99.00% | |
CDK8-IN-12 is an orally active, potent CDK8 inhibitor with a Ki of 14 nM. | ||||
| GC73184 | OUL232 | 943119-42-4 | >99.00% | |
OUL232 is a potent inhibitor of mono-ARTs PARP7, PARP10, PARP11, PARP12, PARP14, and PARP15. | ||||
| GC73189 | MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan | 2414254-51-4 | >97.00% | |
MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan. | ||||
| GC73190 | MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan | 2414254-52-5 | >95.00% | |
MC-Gly-Gly-Phe-Gly-(S)-Cyclopropane-Exatecan is a agent-linker conjugates for ADC, consisting Exatecan. | ||||
